GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » PS Ratio

Envoy Medical (Envoy Medical) PS Ratio : 258.33 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Envoy Medical's share price is $3.10. Envoy Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01. Hence, Envoy Medical's PS Ratio for today is 258.33.

The historical rank and industry rank for Envoy Medical's PS Ratio or its related term are showing as below:

COCH' s PS Ratio Range Over the Past 10 Years
Min: 95   Med: 241.95   Max: 750
Current: 258.35

During the past 3 years, Envoy Medical's highest PS Ratio was 750.00. The lowest was 95.00. And the median was 241.95.

COCH's PS Ratio is ranked worse than
99.38% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 3.295 vs COCH: 258.35

Envoy Medical's Revenue per Sharefor the three months ended in Dec. 2023 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Envoy Medical was 8.70% per year.

Back to Basics: PS Ratio


Envoy Medical PS Ratio Historical Data

The historical data trend for Envoy Medical's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical PS Ratio Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - 72.42

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial - - - - 72.42

Competitive Comparison of Envoy Medical's PS Ratio

For the Medical Devices subindustry, Envoy Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envoy Medical's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's PS Ratio distribution charts can be found below:

* The bar in red indicates where Envoy Medical's PS Ratio falls into.



Envoy Medical PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Envoy Medical's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=3.10/0.012
=258.33

Envoy Medical's Share Price of today is $3.10.
Envoy Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Envoy Medical  (NAS:COCH) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Envoy Medical PS Ratio Related Terms

Thank you for viewing the detailed overview of Envoy Medical's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Envoy Medical (Envoy Medical) Business Description

Traded in Other Exchanges
N/A
Address
4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.